Related Experiment Video
Updated: Aug 7, 2026
09:33
Imaging Approaches to Assessments of Toxicological Oxidative Stress Using Genetically-encoded Fluorogenic Sensors
Published on: February 7, 2018
Oxidative stress markers during a course of hyperthyroidism
Magdalena Lampka1, Roman Junik, Anna Nowicka
1Department of Pathobiochemistry and Clinical Chemistry The Ludwik Rydygier Collegium Medicum, Bydgoszcz, Nicolaus Copernicus University, Toruń. lampka@cm.umk.pl
Endokrynologia Polska
|July 13, 2006
Summary
Hyperthyroidism intensifies oxidative stress, increasing lipid peroxidation products like malondialdehyde (MDA + 4-HNE) in patients. The antioxidant system does not compensate, suggesting these products can serve as oxidative stress markers.
Area of Science:
- Endocrinology
- Biochemistry
- Oxidative Stress Research
Background:
- Oxidative stress is implicated in hyperthyroidism.
- The impact of hyperthyroidism on lipid peroxidation, lipoprotein oxidation, and antioxidant status requires further elucidation.
- Biochemical markers for oxidative stress in hyperthyroidism need evaluation.
Purpose of the Study:
- To assess the influence of hyperthyroidism on lipid peroxidation.
- To evaluate plasma lipoprotein oxidation in hyperthyroid patients.
- To determine changes in the antioxidant defense system and the clinical utility of biochemical parameters as oxidative stress markers.
Main Methods:
- Studied 25 hyperthyroid patients (Graves' disease or toxic multinodular goiter) and 20 healthy controls.
- Measured lipid peroxidation via peroxides and malondialdehyde + 4-hydroxynonenal (MDA + 4-HNE).
- Assayed autoantibodies against oxidized LDL (anti-oxLDL) and measured total antioxidant status (TAS) and erythrocyte superoxide dismutase (SOD) activity.
Main Results:
- Hyperthyroid patients showed significantly higher serum peroxide and MDA + 4-HNE concentrations.
- No significant differences were observed in anti-oxLDL levels between groups.
- Total antioxidant status (TAS) and superoxide dismutase (SOD) activity did not differ between hyperthyroid patients and controls.
Conclusions:
- Excess thyroid hormones intensify oxidative processes in hyperthyroidism.
- The antioxidant system does not show a compensatory response to increased oxidative stress.
- Elevated serum lipid peroxidation products (peroxides, MDA + 4-HNE) are potential markers for oxidative stress in hyperthyroidism.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...